SCHEMBL6205058

SCHEMBL6205058

CCOc1ccc(CNC(=O)c2c[nH]c3c(OCC)cccc3c2=O)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 5/20 0.62
ALDH1A1 P00352 4/20 0.56
MEN1 O00255 4/20 0.56
KMT2A Q03164 4/20 0.56
RAB9A P51151 2/20 0.56
HPGD P15428 2/20 0.56
NPC1 O15118 1/20 0.56
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2D6 P10635 1/20 0.56
CYP2C9 P11712 1/20 0.56
CYP2C19 P33261 1/20 0.56
MAPK10 P53779 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
HSD17B10 Q99714 1/20 0.56
TP53 P04637 2/20 0.54
MAPT P10636 2/20 0.54
ADORA2A P29274 3/20 0.50
ADORA1 P30542 2/20 0.50
CNR1 P21554 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6204974 0.91 POLB (0.64) POLBALDH1A1MEN1KMT2ARAB9A
SCHEMBL6205974 0.87 POLB (0.57) POLBALDH1A1MEN1KMT2ARAB9A
SCHEMBL6206629 0.86 POLB (0.56) POLBALDH1A1MEN1KMT2ARAB9A
SCHEMBL6205372 0.85 POLB (0.55) POLBALDH1A1MEN1KMT2ARAB9A
SCHEMBL6206617 0.85 POLB (0.50) POLBALDH1A1MEN1KMT2ARAB9A
SCHEMBL6207376 0.85 POLB (0.58) POLBALDH1A1MEN1KMT2ARAB9A
SCHEMBL6206717 0.85 POLB (0.54) POLBALDH1A1MEN1KMT2ARAB9A
SCHEMBL6203895 0.85 POLB (0.49) POLBALDH1A1MEN1KMT2ARAB9A
SCHEMBL6206261 0.84 ADORA2A (0.55) POLBALDH1A1MEN1KMT2ARAB9A
SCHEMBL6205837 0.84 POLB (0.78) POLBMEN1KMT2ATP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177177-B1 SUBSTITUTED 4-OXO-QUINOLINE-3-CARBOXAMIDES: GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORP (US) 2005-02-23 EP claimed